Drug:
Reaction: ANAEMIA
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26921447 |
US |
3 | 2 |
Parvovirus B19 infection, Acute kidney injury, Drug ineffective, Anaemia, Respiratory failure, |
||||
PREDNISONE, HUMAN IMMUNOGLOBULIN G, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 102 | 26921544 |
US |
2 | |
Chronic kidney disease, Type 2 diabetes mellitus, Renal cancer, Aortic arteriosclerosis, Computerised tomogram heart, Diabetic nephropathy, Cataract diabetic, Chronic left ventricular failure, Peripheral arterial occlusive disease, Anaemia, Essential hypertension, Anxiety, Lipoprotein (a) increased, Hypertriglyceridaemia, Back pain, Neuralgia, Arthralgia, Fatigue, Dyspnoea, Exercise lack of, Sinus tachycardia, Obesity, Depression, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 103 | 26921660 |
EU |
65 | 1 |
Cardio-respiratory arrest, Malignant neoplasm oligoprogression, Metastases to bone, Pneumonia, Metastases to liver, Anaemia, Disease progression, Haemoptysis, Weight decreased, Bone disorder, Upper respiratory tract infection, |
||||
BEVACIZUMAB, ATEZOLIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, |
||||
| 104 | 26921734 |
US |
77 | 1 |
Anti-neutrophil cytoplasmic antibody positive vasculitis, Skin ulcer, Cellulitis, Anaemia, Limb injury, Renal necrosis, Glomerulonephritis, |
||||
ROSUVASTATIN, APIXABAN, CEPHALEXIN, |
||||
| 105 | 26921751 |
EU |
47 | 1 |
Aorto-oesophageal fistula, Drug ineffective, Tissue injury, Shock haemorrhagic, Pneumonia, Anaemia, |
||||
NIVOLUMAB, CABOZANTINIB, ATEZOLIZUMAB, |
||||
| 106 | 26921835 |
EU |
74 | 1 |
Anaemia, Thrombocytopenia, Neutropenia, Neuropathy peripheral, Atrial fibrillation, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ISATUXIMAB, BORTEZOMIB, LENALIDOMIDE, |
||||
| 107 | 26921840 |
EU |
65 | 1 |
Pyrexia, Anaemia, Hyperglycaemia, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 108 | 26921957 |
US |
70 | 1 |
Anaemia, |
||||
| 109 | 26921987 |
EU |
||
Bacterial infection, Cytokine release syndrome, Neutropenia, Secondary immunodeficiency, Infection, Thrombocytopenia, Febrile neutropenia, Anaemia, Off label use, |
||||
| 110 | 26922081 |
GB |
38 | 2 |
Anaemia, |
||||
| 111 | 26922243 |
CA |
75 | 2 |
Anaemia, Headache, Malaise, Pneumonia, Cough, Chronic sinusitis, Lung disorder, |
||||
METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METHYLPREDNISOLONE, |
||||
| 112 | 26922254 |
EU |
28 | 1 |
Disease progression, Anaemia, Drug ineffective, |
||||
DASATINIB, ASCIMINIB, NILOTINIB, |
||||
| 113 | 26922374 |
EU |
81 | 2 |
Toxic epidermal necrolysis, Neutropenia, Syncope, Acute kidney injury, Rhabdomyolysis, Thrombocytopenia, Coma, Leukopenia, Hypokalaemia, Fall, Escherichia bacteraemia, Nausea, Stomatitis, Fatigue, Flushing, Decreased appetite, Weight decreased, Vomiting, Fatigue, General physical health deterioration, Hyponatraemia, Metabolic acidosis, Respiratory alkalosis, Hypotension, Anaemia, Asthenia, |
||||
CAPECITABINE, CAPECITABINE, ALPRAZOLAM, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, |
||||
| 114 | 26922474 |
US |
1 | |
Diverticulitis, Anaemia, |
||||
RISANKIZUMAB-RZAA, |
||||
| 115 | 26922825 |
CN |
||
Anaemia, Nausea, Fatigue, Leukopenia, Neutropenia, Constipation, Decreased appetite, Transaminases increased, Hypothyroidism, Pneumonitis, Hypophysitis, Myocarditis, Adrenal insufficiency, Type 1 diabetes mellitus, Neuropathy peripheral, Hyperplasia, Rash, |
||||
ATEZOLIZUMAB, PEMBROLIZUMAB, NIVOLUMAB, PENPULIMAB, PEMETREXED, PEMETREXED DISODIUM, CISPLATIN, CARBOPLATIN, |
||||
| 116 | 26922829 |
48 | ||
Acute kidney injury, Hyperbilirubinaemia, Hyperkalaemia, Haemolysis, Anaemia, Metabolic acidosis, Methaemoglobinaemia, Contraindicated product administered, |
||||
| 117 | 26922932 |
US |
2 | |
Anaemia, |
||||
ABEMACICLIB, |
||||
| 118 | 26923066 |
US |
69 | 2 |
Injection site pain, Anaemia, Pruritus, |
||||
DUPILUMAB, |
||||
| 119 | 26923221 |
JP |
||
Leukopenia, Neutropenia, Febrile neutropenia, Thrombocytopenia, Anaemia, Aspartate aminotransferase increased, Alanine aminotransferase increased, Hyponatraemia, Hyperkalaemia, Hypokalaemia, Blood creatinine increased, Hypoalbuminaemia, Decreased appetite, Nausea, Vomiting, Dysgeusia, Fatigue, Malaise, Rash, Constipation, Diarrhoea, |
||||
ATEZOLIZUMAB, CARBOPLATIN, ETOPOSIDE, |
||||
| 120 | 26923300 |
AE |
2 | |
Chronic kidney disease, Osteonecrosis, Anaemia, Arteriosclerosis, |
||||
FULVESTRANT, FULVESTRANT, ERGOCALCIFEROL, DENOSUMAB, PALBOCICLIB, |
||||
| 121 | 26923605 |
US |
67 | 2 |
Colitis, Acute kidney injury, Dyspnoea, Dyspnoea, Platelet count decreased, Pleural effusion, Ileus, Anaemia, Generalised oedema, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMETREXED, PEMETREXED DISODIUM, CARBOPLATIN, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, DIAZEPAM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, SENNOSIDES 8.6 MG TABLETS, SENNOSIDES, SENNA LEAF, SENNA, ALPRAZOLAM, ERGOCALCIFEROL, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FOLIC ACID, ALPRAZOLAM, FUROSEMIDE, METOLAZONE, |
||||
| 122 | 26923979 |
GB |
83 | 1 |
Anaemia, Vascular stent thrombosis, Platelet aggregation increased, Drug ineffective, |
||||
CLOPIDOGREL, CLOPIDOGREL BISULFATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, IBRUTINIB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 123 | 26924386 |
RU |
63 | 2 |
Hepatotoxicity, Anaemia, |
||||
TALAZOPARIB, |
||||
| 124 | 26924527 |
US |
||
Hypoxia, Pneumonia, Hyperglycaemia, Peripheral sensory neuropathy, Dyspnoea, Lymphocyte count decreased, Urinary tract infection, Gastrointestinal disorder, Fatigue, Diarrhoea, Platelet count decreased, Muscular weakness, Cough, Upper respiratory tract infection, Infestation, Anaemia, White blood cell count decreased, Neutrophil count decreased, Nausea, Constipation, Infection, Cognitive disorder, Oedema peripheral, Rash maculo-papular, Peripheral motor neuropathy, Vomiting, Insomnia, Gastrooesophageal reflux disease, Blood creatinine increased, Intentional product use issue, |
||||
DARATUMUMAB, IXAZOMIB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 125 | 26924630 |
GB |
1 | |
Anaemia, |
||||
CLOZAPINE, |
||||
| 126 | 26924726 |
US |
41 | 1 |
Liver function test increased, Blood potassium abnormal, Anaemia, Hepatic function abnormal, |
||||
GUSELKUMAB, AZATHIOPRINE, PREDNISONE, |
||||
| 127 | 26924976 |
JP |
||
Febrile neutropenia, Pneumonia, Hypothyroidism, Urinary retention, Hypersensitivity, Rash, Anaemia, Constipation, |
||||
DURVALUMAB, OLAPARIB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, |
||||
| 128 | 26925143 |
US |
59 | 2 |
Full blood count decreased, Anaemia, Neutropenia, |
||||
LENALIDOMIDE, LENALIDOMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, EPINEPHRINE, ADRENALINUM, GABAPENTIN, HYDROCORTISONE SODIUM SUCCINATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 129 | 26925189 |
US |
||
Anaemia, Infection, |
||||
ELRANATAMAB-BCMM, |
||||
| 130 | 26925254 |
US |
89 | 1 |
Anaemia, Red blood cell sedimentation rate increased, Oedema peripheral, Weight increased, Retinal vein occlusion, Osteopenia, Renal impairment, Stress fracture, Neutropenia, Sternal fracture, C-reactive protein increased, Uveitis, Rebound effect, Off label use, Vein rupture, Spinal fracture, Serum ferritin increased, |
||||
PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, TOCILIZUMAB, AZACITIDINE, AZACITIDINE FOR, VORICONAZOLE, VORICONAZOLE INJECTION, ACYCLOVIR, ATOVAQUONE, ATOVAQUONE ORAL SUSPENSION, |
||||
| 131 | 26925426 |
BR |
2 | |
Plasma cell myeloma, Drug ineffective, Pain, Anaemia, |
||||
BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LENALIDOMIDE, |
||||
| 132 | 26925537 |
80 | 2 | |
Pulmonary oedema, Malignant neoplasm progression, Interstitial lung disease, Anaemia, Aspartate aminotransferase increased, Alanine aminotransferase increased, SARS-CoV-2 test positive, |
||||
ABEMACICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, DENOSUMAB, |
||||
| 133 | 26925565 |
EU |
72 | 2 |
Loss of consciousness, Anaemia, Thrombocytopenia, |
||||
DOSTARLIMAB, |
||||
| 134 | 26925974 |
JP |
||
Oesophageal candidiasis, Candida infection, Arrhythmia, Folliculitis, Eczema, Anaemia, Ocular hyperaemia, Injection site reaction, Dyshidrotic eczema, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 135 | 26926222 |
US |
74 | 2 |
Post procedural complication, Anaemia, |
||||
DUPILUMAB, |
||||
| 136 | 26926332 |
EU |
67 | |
Thrombocytopenia, Neutropenia, Anaemia, Off label use, |
||||
RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, HYDROXYUREA, |
||||
| 137 | 26926455 |
CA |
39 | |
Nephrolithiasis, Anaemia, Blood phosphorus decreased, |
||||
EPTINEZUMAB-JJMR, TOPIRAMATE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, HYDROCORTISONE, MAGNESIUM, CALCIUM, FOLIC ACID, |
||||
| 138 | 26929161 |
1 | ||
Stem cell transplant, Anaemia, Vitamin B12 decreased, Bone pain, |
||||
LENALIDOMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FOLIC ACID, GABAPENTIN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXYCODONE, PANTOPRAZOLE, VALSARTAN, VALSARTAN ORAL, |
||||
| 139 | 26930300 |
81 | 1 | |
Anaemia, Oedema, Gait disturbance, Exercise tolerance decreased, Vomiting, Muscular weakness, |
||||
ADALIMUMAB, |
||||
| 140 | 26915162 |
EU |
71 | 1 |
Clostridium difficile colitis, Colitis, Hepatitis cholestatic, Thrombocytopenia, Pancytopenia, Clostridium difficile colitis, Anaemia, Dysphagia, Hypergammaglobulinaemia, Epstein-Barr virus infection, Urinary tract infection bacterial, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, DAPTOMYCIN, CARBAMAZEPINE, LEVETIRACETAM, FOLIC ACID, CALCIFEDIOL, VALPROIC ACID, |
||||
| 141 | 26915180 |
EU |
55 | 2 |
Leukopenia, Thrombocytopenia, Thrombosis, Anaemia, Body temperature increased, General physical health deterioration, |
||||
CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 142 | 26915268 |
|||
Circulatory collapse, Anaphylactic reaction, Angioedema, Intentional product misuse, Anaemia, |
||||
DICLOFENAC, DICLOFENAC SODIUM, TIZANIDINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXLANSOPRAZOLE, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE, SULFASALAZINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, FOLIC ACID, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, CARBAMAZEPINE, LACOSAMIDE, AMLODIPINE, |
||||
| 143 | 26915497 |
EU |
55 | 2 |
Pancytopenia, Feeling hot, Hot flush, Poor quality sleep, Flatulence, Leukocytosis, Thrombocytopenia, Musculoskeletal stiffness, Weight increased, Increased appetite, Decreased appetite, Pain in extremity, Myalgia, Anaemia, Fatigue, Diarrhoea, Dizziness, Headache, Nausea, Therapeutic product effect incomplete, Cytogenetic analysis abnormal, Drug ineffective, |
||||
IMATINIB, IMATINIB, PANTOPRAZOLE, PANTOPRAZOLE, CELECOXIB, ELTROMBOPAG OLAMINE, ELTROMBOPAG, NILOTINIB, DASATINIB, CALCIUM CARBONATE, ANTACID, LISINOPRIL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PAROXETINE HYDROCHLORIDE, OXAZEPAM, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, HYDROXYUREA, AMLODIPINE, AMLODIPINE, |
||||
| 144 | 26915528 |
EU |
82 | 1 |
International normalised ratio increased, Anaemia, |
||||
OSELTAMIVIR PHOSPHATE, WARFARIN SODIUM, WARFARIN, |
||||
| 145 | 26915533 |
CA |
80 | 1 |
Abdominal distension, Abdominal pain, Anaemia, Analgesic therapy, Appendicitis, Appendicolith, Ascites, Bacterial infection, Blood cholesterol increased, Blood phosphorus increased, Blood uric acid increased, Cardiogenic shock, Chronic obstructive pulmonary disease, Condition aggravated, Constipation, Diabetes mellitus, Drug hypersensitivity, Drug intolerance, Drug therapy, Dry mouth, Dyspnoea, General physical health deterioration, Hyperphosphataemia, Intentional product misuse, Multiple organ dysfunction syndrome, Myasthenia gravis, Nausea, Neuralgia, Pulmonary embolism, Off label use, Sepsis, Sleep disorder, Sleep disorder therapy, Somnolence, Stress, Swelling, Thrombosis, Ventricular fibrillation, Vomiting, Hyponatraemia, |
||||
CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, OSELTAMIVIR, OSELTAMIVIR PHOSPHATE, PHYTONADIONE, |
||||
| 146 | 26915713 |
MX |
51 | 2 |
Breast cancer, Malignant neoplasm progression, Cardio-respiratory arrest, Hepatitis, Asthenia, Back pain, Pruritus, Hair growth abnormal, Weight increased, Increased appetite, Dyspepsia, Drug hypersensitivity, Pharyngeal inflammation, Dyspepsia, Pharyngeal inflammation, Dysphagia, Decreased immune responsiveness, Anaemia, Constipation, Dizziness, Influenza, Pain, Malaise, Arthralgia, Pyrexia, Eye infection, Photophobia, Dry skin, Weight decreased, Bone pain, Drug ineffective, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
| 147 | 26915852 |
CN |
53 | 1 |
Death, Metastases to central nervous system, Anaemia, Platelet count decreased, White blood cell count decreased, Nausea, Diarrhoea, |
||||
IRINOTECAN HYDROCHLORIDE, LEUCOVORIN CALCIUM, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 148 | 26916541 |
KR |
6 | 2 |
Pancytopenia, Pruritus, Anaemia, Myalgia, Nausea, Tremor, Abdominal pain, Rash, Red blood cell transfusion, Asthenia, Syncope, Cytopenia, Vomiting, Acute kidney injury, Functional endoscopic sinus surgery, Febrile neutropenia, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, TETRACYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE, |
||||
| 149 | 26916615 |
CN |
||
Rash, Seizure, Urinary retention, Hot flush, Fatigue, Anaemia, Weight increased, Asthenia, Hypertension, Pruritus, Bone pain, Back pain, Constipation, Blood alkaline phosphatase increased, Arthralgia, Pain in extremity, Fall, |
||||
APALUTAMIDE, |
||||
| 150 | 26916805 |
EU |
2 | |
Anaemia, COVID-19, Drug ineffective, |
||||
BENDAMUSTINE HCL, BRENTUXIMAB VEDOTIN, RITUXIMAB, DOXORUBICIN, DACARBAZINE, |
||||
| 151 | 26916810 |
82 | ||
Anaemia, Melaena, |
||||
RIVAROXABAN, FUROSEMIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, VALSARTAN, VALSARTAN ORAL, ALFUZOSIN HYDROCHLORIDE, MONTELUKAST SODIUM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, FAMOTIDINE, |
||||
| 152 | 26917057 |
56 | 2 | |
Abnormal uterine bleeding, Anaemia, Endometrial cancer stage III, |
||||
RIOCIGUAT, |
||||
| 153 | 26917363 |
EU |
||
Blood loss anaemia, Splenomegaly, Anaemia, Pain in extremity, Mean cell haemoglobin concentration abnormal, Platelet count abnormal, Therapy partial responder, |
||||
RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, AMLODIPINE, VALSARTAN, VALSARTAN ORAL, BISOPROLOL FUMARATE, DOXAZOSIN, DOXAZOSIN MESYLATE, APIXABAN, PROPAFENONE, TORSEMIDE, EPLERENONE, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, AMITRIPTYLINE HYDROCHLORIDE, FENOFIBRATE, ALPRAZOLAM, DABIGATRAN ETEXILATE, |
||||
| 154 | 26917417 |
US |
||
Death, Neuropathy peripheral, Cardiomyopathy, Cardiac failure, Leukopenia, Neutropenia, Thrombocytopenia, Atrial fibrillation, Lymphopenia, Anaemia, Off label use, |
||||
DARATUMUMAB, |
||||
| 155 | 26917690 |
CN |
68 | 1 |
Tubulointerstitial nephritis, Off label use, Immune-mediated dermatitis, Eczema, Immune-mediated nephritis, Immune-mediated adverse reaction, Renal impairment, Decreased appetite, Papule, Pruritus, Rash, Skin exfoliation, Immune thrombocytopenia, Platelet production decreased, Anaemia, Hyperglycaemia, |
||||
OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, |
||||
| 156 | 26917954 |
US |
67 | 2 |
Anaemia, Dyspnoea, Weight decreased, Diarrhoea, Drug ineffective, Constipation, Choking, Tremor, Product dose omission issue, Illness, Headache, Fall, Wrist fracture, Dizziness, Balance disorder, Migraine, Cough, Decreased appetite, Pruritus, Depression, Gastrointestinal disorder, Wound, Back pain, Intentional product use issue, Neck pain, Mobility decreased, Osteoporosis, Breath sounds abnormal, Lung disorder, Therapeutic response unexpected, Head discomfort, |
||||
NINTEDANIB, NINTEDANIB, NINTEDANIB, NINTEDANIB, |
||||
| 157 | 26918174 |
CA |
59 | 2 |
Blood pressure increased, Syncope, Blood iron decreased, Cystitis, Cellulitis, Back pain, Neuralgia, Pain, Hypoaesthesia, Paraesthesia, Diabetes mellitus, Cholelithiasis, Haemorrhage, Hypothyroidism, Endometrial cancer stage I, Second primary malignancy, Nephrolithiasis, Renal impairment, Renal failure, Procedural pain, Carcinoid tumour, Metastases to ovary, Metastases to fallopian tube, Metastases to bladder, Malignant neoplasm progression, Palpitations, Arthralgia, Subcutaneous haematoma, Pain in extremity, Muscle spasms, Peripheral swelling, Serum serotonin increased, Vertigo, Urine output decreased, Myalgia, Contusion, Hepatic pain, Muscle tightness, Groin pain, Nasopharyngitis, White blood cell count increased, Haemoglobin decreased, Urinary tract infection, Acne, Liver function test increased, Hypomenorrhoea, Polyp, Blood urine present, Abdominal adhesions, Endometriosis, Endometrial hyperplasia, Poor quality sleep, Pyrexia, Chills, Cough, Migraine, Anaemia, Blood pressure systolic decreased, Blood pressure diastolic decreased, Joint swelling, Arthritis, Crystal arthropathy, Gout, Joint stiffness, Malaise, Peripheral swelling, Erythema, Joint swelling, Rash pruritic, Asthenia, Heart rate decreased, Vomiting, Dizziness, Abdominal pain, Abdominal tenderness, Rash papular, Diarrhoea, Fatigue, Nausea, Decreased appetite, Injection site mass, Injection site pain, Injection site pain, Injection site reaction, Injection site erythema, Needle issue, |
||||
AMLODIPINE, AMLODIPINE, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 158 | 26918614 |
CA |
1 | |
Intestinal anastomosis, Therapeutic product effect incomplete, Inflammation, Anaemia, |
||||
| 159 | 26919160 |
66 | 2 | |
Neutropenia, Metastases to meninges, Anaemia, Alopecia, |
||||
| 160 | 26919182 |
EU |
21 | 2 |
Oedema peripheral, Blood pressure increased, Hypotension, Constipation, Haemorrhage, Anaemia, Blood fibrinogen decreased, |
||||
ALBUTEROL SULFATE, ALBUTEROL, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, CAPTOPRIL, TRANEXAMIC ACID, DEXMEDETOMIDINE, |
||||
| 161 | 26919287 |
EU |
2 | |
Anaemia, |
||||
CLOZAPINE, |
||||
| 162 | 26919290 |
US |
37 | 2 |
Acute kidney injury, Anaemia, Hypertension, |
||||
ECULIZUMAB, |
||||
| 163 | 26920892 |
EU |
57 | 1 |
Hypothyroidism, Neutropenia, Neutropenia, Neutropenia, Anaemia, Anaemia, Anaemia, Anaemia, Oedema peripheral, Mucosal inflammation, |
||||
PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, |
||||
| 164 | 26921175 |
26 | 1 | |
Peritonitis, Candida sepsis, Anaemia, Thrombocytopenia, Gamma-glutamyltransferase increased, Neutropenia, Blood alkaline phosphatase increased, Off label use, |
||||
CETUXIMAB, CETUXIMAB, CETUXIMAB, ENCORAFENIB, ENCORAFENIB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, OXALIPLATIN, DIMENHYDRINATE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
| 165 | 26923706 |
64 | 2 | |
Anaemia, Infusion related reaction, Hypotension, Chest pain, Cough, Wheezing, Atypical pneumonia, Pneumonia, Gastrointestinal haemorrhage, Haemorrhoids, |
||||
MELOXICAM, |
||||
| 166 | 26910229 |
CA |
73 | 2 |
Gastrointestinal angiodysplasia, Hepatic enzyme increased, Red blood cell transfusion, Dyspnoea, Asthenia, Anaemia, Acute kidney injury, |
||||
RIVAROXABAN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, BISOPROLOL FUMARATE, CEFADROXIL, CELECOXIB, DEXLANSOPRAZOLE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, FERROUS SULFATE, FUROSEMIDE, ALBUTEROL SULFATE, ALBUTEROL, DULOXETINE HYDROCHLORIDE, SPIRONOLACTONE, TIOTROPIUM BROMIDE, |
||||
| 167 | 26910521 |
CA |
59 | 2 |
Blood pressure increased, Syncope, Blood iron decreased, Cystitis, Cellulitis, Back pain, Neuralgia, Pain, Hypoaesthesia, Paraesthesia, Diabetes mellitus, Cholelithiasis, Haemorrhage, Hypothyroidism, Endometrial cancer stage I, Second primary malignancy, Nephrolithiasis, Renal impairment, Renal failure, Procedural pain, Carcinoid tumour, Metastases to ovary, Metastases to fallopian tube, Metastases to bladder, Malignant neoplasm progression, Palpitations, Arthralgia, Subcutaneous haematoma, Pain in extremity, Muscle spasms, Peripheral swelling, Serum serotonin increased, Vertigo, Urine output decreased, Myalgia, Contusion, Hepatic pain, Muscle tightness, Groin pain, Nasopharyngitis, White blood cell count increased, Haemoglobin decreased, Urinary tract infection, Acne, Liver function test increased, Hypomenorrhoea, Polyp, Blood urine present, Abdominal adhesions, Endometriosis, Endometrial hyperplasia, Poor quality sleep, Pyrexia, Chills, Cough, Migraine, Anaemia, Blood pressure systolic decreased, Blood pressure diastolic decreased, Joint swelling, Arthritis, Crystal arthropathy, Gout, Joint stiffness, Malaise, Peripheral swelling, Erythema, Joint swelling, Rash pruritic, Asthenia, Heart rate decreased, Vomiting, Dizziness, Abdominal pain, Abdominal tenderness, Rash papular, Diarrhoea, Fatigue, Nausea, Decreased appetite, Injection site mass, Injection site pain, Injection site pain, Injection site reaction, Injection site erythema, Needle issue, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, AMLODIPINE, AMLODIPINE, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 168 | 26910647 |
CO |
2 | |
Hepatic cirrhosis, Surgery, Ascites, Contusion, Post procedural swelling, Medical procedure, Ill-defined disorder, Blood glucose increased, Blood pressure abnormal, Anaemia, Platelet count abnormal, |
||||
ROMIPLOSTIM, |
||||
| 169 | 26910729 |
EU |
48 | 1 |
Presyncope, Nausea, Anaemia, Deep vein thrombosis, |
||||
CISPLATIN, CAPECITABINE, PEMBROLIZUMAB, |
||||
| 170 | 26911183 |
JP |
40 | 2 |
Neutropenia, Anaemia, |
||||
DOXORUBICIN, DOXORUBICIN, CISPLATIN, CISPLATIN, ETOPOSIDE, ETOPOSIDE, MITOTANE, MITOTANE, |
||||
| 171 | 26911296 |
JP |
76 | 2 |
Leukopenia, Neutropenia, Anaemia, Dysgeusia, Product use in unapproved indication, |
||||
ERIBULIN MESYLATE, ERIBULIN MESYLATE, PEGFILGRASTIM, |
||||
| 172 | 26911299 |
CN |
53 | 1 |
Anaemia, Hyperbilirubinaemia, Asthenia, Decreased appetite, Nausea, Alanine aminotransferase increased, Aspartate aminotransferase increased, Cholecystitis, Renal cyst, Intra-abdominal fluid collection, Ascites, Activated partial thromboplastin time ratio decreased, Blood albumin decreased, |
||||
ALECTINIB HYDROCHLORIDE, SIROLIMUS, |
||||
| 173 | 26911306 |
JP |
77 | 2 |
Leukopenia, Neutropenia, Anaemia, Product use in unapproved indication, |
||||
ERIBULIN MESYLATE, ERIBULIN MESYLATE, PEGFILGRASTIM, |
||||
| 174 | 26911307 |
JP |
78 | 2 |
Leukopenia, Dysgeusia, Neutropenia, Anaemia, Product use in unapproved indication, |
||||
ERIBULIN MESYLATE, ERIBULIN MESYLATE, PEGFILGRASTIM, |
||||
| 175 | 26911313 |
JP |
82 | 1 |
Leukopenia, Neutropenia, Neuropathy peripheral, Anaemia, Product use in unapproved indication, |
||||
ERIBULIN MESYLATE, ERIBULIN MESYLATE, PEGFILGRASTIM, |
||||
| 176 | 26911332 |
US |
1 | |
Fatigue, Anaemia, White blood cell count decreased, |
||||
RELUGOLIX, |
||||
| 177 | 26911673 |
CN |
69 | 1 |
Hypokalaemia, Immune-mediated enterocolitis, Febrile neutropenia, Myelosuppression, Pneumonia, Upper gastrointestinal haemorrhage, Thrombosis, Hypocalcaemia, Hypochloraemia, Hyponatraemia, Anaemia, Hypoalbuminaemia, Hypomagnesaemia, Oral disorder, Pyrexia, Stomatitis, Platelet count decreased, White blood cell count decreased, Cough, Dizziness, Fatigue, |
||||
NIVOLUMAB, CISPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 178 | 26911785 |
EU |
21 | 2 |
Oedema peripheral, Blood pressure increased, Hypotension, Constipation, Haemorrhage, Anaemia, Blood fibrinogen decreased, |
||||
ALBUTEROL SULFATE, ALBUTEROL, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, TRANEXAMIC ACID, DEXMEDETOMIDINE, CAPTOPRIL, |
||||
| 179 | 26911840 |
US |
||
Anaemia, |
||||
ISOTRETINOIN, ISOTRETINOIN, |
||||
| 180 | 26911919 |
CA |
59 | 2 |
Blood pressure increased, Syncope, Blood iron decreased, Cystitis, Cellulitis, Back pain, Neuralgia, Pain, Hypoaesthesia, Paraesthesia, Diabetes mellitus, Cholelithiasis, Haemorrhage, Hypothyroidism, Endometrial cancer stage I, Second primary malignancy, Nephrolithiasis, Renal impairment, Renal failure, Procedural pain, Carcinoid tumour, Metastases to ovary, Metastases to fallopian tube, Metastases to bladder, Malignant neoplasm progression, Palpitations, Arthralgia, Subcutaneous haematoma, Pain in extremity, Muscle spasms, Peripheral swelling, Serum serotonin increased, Vertigo, Urine output decreased, Myalgia, Contusion, Hepatic pain, Muscle tightness, Groin pain, Nasopharyngitis, White blood cell count increased, Haemoglobin decreased, Urinary tract infection, Acne, Liver function test increased, Hypomenorrhoea, Polyp, Blood urine present, Abdominal adhesions, Endometriosis, Endometrial hyperplasia, Poor quality sleep, Pyrexia, Chills, Cough, Migraine, Anaemia, Blood pressure systolic decreased, Blood pressure diastolic decreased, Joint swelling, Arthritis, Crystal arthropathy, Gout, Joint stiffness, Malaise, Peripheral swelling, Erythema, Joint swelling, Rash pruritic, Asthenia, Heart rate decreased, Vomiting, Dizziness, Abdominal pain, Abdominal tenderness, Rash papular, Diarrhoea, Fatigue, Nausea, Decreased appetite, Injection site mass, Injection site pain, Injection site pain, Injection site reaction, Injection site erythema, Needle issue, |
||||
AMLODIPINE, AMLODIPINE, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 181 | 26912009 |
CA |
||
Acne, Nausea, Serum ferritin decreased, Concomitant disease aggravated, Anaemia, Colitis ulcerative, C-reactive protein increased, Swelling face, Dizziness, Weight increased, Lack of concomitant drug effect, Labelled drug-drug interaction issue, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, IRON, MESALAMINE, PANTOPRAZOLE, PREDNISONE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, |
||||
| 182 | 26912086 |
EU |
83 | 2 |
Polyneuropathy, Anaemia, |
||||
CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), DOSTARLIMAB, |
||||
| 183 | 26912093 |
EU |
26 | 1 |
Blast crisis in myelogenous leukaemia, Treatment failure, Drug ineffective, Disease progression, Anaemia, |
||||
IMATINIB, DASATINIB, ASCIMINIB, BOSUTINIB, |
||||
| 184 | 26912121 |
EU |
60 | 1 |
Gastric ulcer haemorrhage, Anaemia, |
||||
ETOPOSIDE, METHOTREXATE SODIUM, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, IFOSFAMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYTARABINE, RITUXIMAB, |
||||
| 185 | 26912443 |
EU |
||
Seizure, Arthritis, Herpes virus infection, Upper respiratory tract infection, Anaemia, |
||||
SACITUZUMAB GOVITECAN, |
||||
| 186 | 26912478 |
EU |
77 | 2 |
Anaemia, Acute kidney injury, Diarrhoea, |
||||
IRINOTECAN HYDROCHLORIDE, LEUCOVORIN CALCIUM, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 187 | 26912774 |
CN |
51 | 1 |
Myelosuppression, Infection, Asthenia, Anaemia, Abdominal pain upper, Insomnia, Pyrexia, |
||||
CYTARABINE, IDARUBICIN HYDROCHLORIDE, |
||||
| 188 | 26913101 |
EU |
60 | 1 |
Gastric ulcer haemorrhage, Anaemia, |
||||
RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, IFOSFAMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYTARABINE, VINCRISTINE SULFATE, ETOPOSIDE, |
||||
| 189 | 26913181 |
EU |
||
Hepatotoxicity, Rash maculo-papular, Hypothyroidism, Colitis, Pneumonitis, Alanine aminotransferase increased, Blood alkaline phosphatase increased, Hypersensitivity, Anaemia, Anorectal infection, Aspartate aminotransferase increased, Blood bilirubin increased, Cholangitis, Colitis, Diarrhoea, Fatigue, Dyspnoea, Febrile neutropenia, Gastritis, Hepatotoxicity, Hypertension, Kidney infection, Kidney infection, Pneumonia, Neuralgia, Neutrophil count decreased, Platelet count decreased, Psychotic disorder, Sepsis, Embolism, Urinary fistula, Urinary tract infection, Uterine infection, Vaginal haemorrhage, Arthritis, Blood corticotrophin decreased, Blood prolactin abnormal, Vision blurred, Blood creatinine increased, Diabetes mellitus, Dry eye, Oesophageal infection, Pyrexia, Gamma-glutamyltransferase increased, Headache, Hyperglycaemia, Hyperthyroidism, Hypomagnesaemia, Hypophysitis, Pain, Peripheral sensory neuropathy, Pharyngitis, Proteinuria, Pruritus, Renal disorder, Urinary tract disorder, Skin disorder, Blood thyroid stimulating hormone increased, |
||||
ATEZOLIZUMAB, ATEZOLIZUMAB, BEVACIZUMAB, BEVACIZUMAB, |
||||
| 190 | 26913324 |
US |
71 | 2 |
Anaemia, Red blood cell count decreased, Fatigue, Dyspnoea exertional, Loss of personal independence in daily activities, Pain in extremity, Gait disturbance, Hypokinesia, Chronic obstructive pulmonary disease, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 191 | 26913345 |
82 | 2 | |
Hypertension, Amylase increased, Photosensitivity reaction, Depression, Hallucination, Speech disorder, Oedema, Hypotension, Bradycardia, Anaemia, Arthralgia, |
||||
LORLATINIB, BRIGATINIB, ALECTINIB HYDROCHLORIDE, |
||||
| 192 | 26913680 |
US |
81 | 2 |
Anaemia, Small intestinal obstruction, |
||||
POMALIDOMIDE, LENALIDOMIDE, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, EZETIMIBE, HYDROCHLOROTHIAZIDE, LATANOPROST, TELMISARTAN, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 193 | 26913794 |
68 | 2 | |
Renal failure, Blood creatinine increased, Thrombocytopenia, Anaemia, Off label use, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 194 | 26913865 |
US |
7 | 2 |
Optic atrophy, Anaemia, |
||||
SELUMETINIB, |
||||
| 195 | 26905424 |
CN |
53 | 1 |
Anaemia, Nausea, Vomiting, Gastrooesophageal reflux disease, Dyspepsia, Eructation, Asthenia, Decreased appetite, Abdominal pain, |
||||
OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CAPECITABINE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 196 | 26905441 |
JP |
8 | 2 |
Thrombosis, Anaemia, Blood creatinine increased, |
||||
| 197 | 26905521 |
JP |
8 | 1 |
Renal impairment, Anaemia, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN, CISPLATIN, |
||||
| 198 | 26905736 |
US |
90 | 2 |
Death, Hyperkalaemia, Chronic kidney disease, Blood creatine increased, Blood pressure inadequately controlled, Glomerular filtration rate decreased, Anaemia, |
||||
DAPAGLIFLOZIN, AMLODIPINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, DARBEPOETIN ALFA, FERROUS SULFATE, FUROSEMIDE, HYDROXYZINE, LATANOPROST, LOVASTATIN, MIRABEGRON, PATIROMER, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, TIMOLOL, |
||||
| 199 | 26905759 |
EU |
||
Thrombocytopenia, Febrile neutropenia, Anaemia, Neutropenia, Acute kidney injury, Aspartate aminotransferase increased, Alanine aminotransferase increased, Mucosal inflammation, |
||||
RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PREDNISONE, |
||||
| 200 | 26905785 |
US |
87 | 1 |
Anaemia, |
||||
BISOPROLOL FUMARATE, RIVAROXABAN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUMETANIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
